Integrative pan-cancer analysis and experiment validation identified GLS as a biomarker in tumor progression, prognosis, immune microenvironment, and immunotherapy

Dongming Li, Xueyuan Cao, Yangyu Zhang et al.|Scientific Reports|2025

Cited by 14